ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1976

Sequencing of the MHC Region Defines HLA-DQA1 As Driven Risk for Anti-Citrullinated Protein Antibodies (ACPA)-Positive Rheumatoid Arthritis in Han Population

Jianping Guo1, Tao Zhang2, Hongzhi Cao2, Xiaowei Li2, Mengru Liu1, Yundong Zou1 and Zhan-Guo Li1, 1Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China, 2Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: ACPA, genetics, human leukocyte antigens (HLA) and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Session Title: Genetics, Genomics and Proteomics Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The strong genetic contribution of the major histocompatibility complex (MHC) to rheumatoid arthritis (RA) susceptibility has been generally attributed to HLA-DRB1. However, due to the high linkage disequilibrium in the MHC region, it is difficult to define the ‘real’ or/and additional independent genetic risks using the conventional HLA genotyping or chip-based microarray technology.

Methods: To fine map HLA region and identify novel variants contributing to RA, we performed a deep sequencing for entire MHC region for discovery and classical HLA-typing for validation in 2773 subjects of Han ancestry (961 cases and 1812 controls). We analyzed HLA alleles, amino acids, SNPs, and indels across the MHC region to define the association for anti-citrullinated protein antibodies (ACPA)-positive RA.

Results: We identified HLA-DQa1:160D as a novel and the strongest independent genetic risk for anti-citrullinated protein antibodies (ACPA)-positive RA in Han population (P = 6.16 x 10−36, OR=2.29). Further stepwise conditional analysis revealed that DRb1:37N has an independent protective effect on ACPA–positive RA (P = 5.81 x 10−16, OR=0.49). The DQa1:160 coding allele DQA1*0303 displayed high impact on joint radiographic severity, especially in patients with early disease and smoking (P = 3.02 x 10−5).

Conclusion: We provide the first evidence that HLA-DQA1, instead of HLA-DRB1, is the strongest and independent genetic risk for ACPA-positive RA in Chinese Han. DRb1:37N is an independent protective factor for ACPA-positive RA. Our study also illustrates the value of MHC deep sequencing for fine mapping disease risk variants in the MHC region.


Disclosure: J. Guo, None; T. Zhang, None; H. Cao, None; X. Li, None; M. Liu, None; Y. Zou, None; Z. G. Li, None.

To cite this abstract in AMA style:

Guo J, Zhang T, Cao H, Li X, Liu M, Zou Y, Li ZG. Sequencing of the MHC Region Defines HLA-DQA1 As Driven Risk for Anti-Citrullinated Protein Antibodies (ACPA)-Positive Rheumatoid Arthritis in Han Population [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/sequencing-of-the-mhc-region-defines-hla-dqa1-as-driven-risk-for-anti-citrullinated-protein-antibodies-acpa-positive-rheumatoid-arthritis-in-han-population/. Accessed January 27, 2023.
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sequencing-of-the-mhc-region-defines-hla-dqa1-as-driven-risk-for-anti-citrullinated-protein-antibodies-acpa-positive-rheumatoid-arthritis-in-han-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences